Respiratory Effectiveness Group (REG)

The Respiratory Effectiveness Group (REG) is a not-for-profit initiative established by international experts in real-life and comparative effectiveness research in respiratory medicine.

The Group sets quality standards in the field of real-life research and improves understanding of the optimum role of real-life data to inform meaningful clinical practice guidelines, drug licensing and post-marketing surveillance processes and improved patient care.

The Respiratory Effectiveness Group (REG) is an investigator-led, global not-for-profit respiratory medicine research and think-tank initiative that has been set up in recognition of the potential value of real-life research and the need to harness real-life evidence to inform meaningful practice guidelines, drug licensing and prescribing decisions.

Through Their network international experts in real-life respiratory research working at guideline bodies, research organisations, in primary care practice and in collaboration with pharmaceutical and medical companies, work to raise the profile of real-life research and to lead by example and establish a position of credibility from which to engage in advocacy activities including education to raise awareness and strengthen the value, quality and penetration of real-life study data.